A 1-year follow-up study on immunological changes following deep brain stimulation in patients with epilepsy
Abstract The aim of this study was to evaluate the effects of deep brain stimulation of the anterior nucleus of the thalamus (ANT-DBS) on systemic inflammatory responses in patients with drug-resistant epilepsy (DRE). Twenty-two Finnish patients with ANT-DBS implantation were enrolled in this pilot...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2021-07-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-021-93265-x |
| _version_ | 1818845165054328832 |
|---|---|
| author | Pabitra Basnyat Soila Järvenpää Jani Raitanen Marko Pesu Kai Lehtimäki Jukka Peltola |
| author_facet | Pabitra Basnyat Soila Järvenpää Jani Raitanen Marko Pesu Kai Lehtimäki Jukka Peltola |
| author_sort | Pabitra Basnyat |
| collection | DOAJ |
| description | Abstract The aim of this study was to evaluate the effects of deep brain stimulation of the anterior nucleus of the thalamus (ANT-DBS) on systemic inflammatory responses in patients with drug-resistant epilepsy (DRE). Twenty-two Finnish patients with ANT-DBS implantation were enrolled in this pilot study. Changes in plasma interleukin-6 (IL-6) and interleukin-10 (IL-10) levels were examined using generalized estimating equation models at seven time points (before DBS surgery and 1, 2, 3, 6, 9 and 12 months after implantation). In the whole group, the IL-6/IL-10 ratio decreased significantly over time following ANT-DBS, while the decrease in IL-6 levels and increase in IL-10 levels were not significant. In the responder and nonresponder groups, IL-6 levels remained unchanged during the follow-up. Responders had significantly lower pre-DBS IL-10 levels before the ANT-DBS treatment than nonresponders, but the levels significantly increased over time after the treatment. In addition, responders had a higher pre-DBS IL-6/IL-10 ratio than nonresponders, and the ratio decreased for both groups after treatment, but the decrease did not reach the level of statistical significance. The rate of decrease in the ratio per month tended to be higher in responders than in nonresponders. These results may highlight the anti-inflammatory properties of ANT-DBS treatment associated with its therapeutic effectiveness in patients with DRE. Additional studies are essential to evaluate the potential of the proinflammatory cytokine IL-6, the anti-inflammatory cytokine IL-10, and their ratio as biomarkers to evaluate the therapeutic response to DBS treatment, which could facilitate treatment optimization. |
| first_indexed | 2024-12-19T05:25:19Z |
| format | Article |
| id | doaj.art-3eb092a38bce42ac804b62bfdb577a75 |
| institution | Directory Open Access Journal |
| issn | 2045-2322 |
| language | English |
| last_indexed | 2024-12-19T05:25:19Z |
| publishDate | 2021-07-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj.art-3eb092a38bce42ac804b62bfdb577a752022-12-21T20:34:23ZengNature PortfolioScientific Reports2045-23222021-07-011111710.1038/s41598-021-93265-xA 1-year follow-up study on immunological changes following deep brain stimulation in patients with epilepsyPabitra Basnyat0Soila Järvenpää1Jani Raitanen2Marko Pesu3Kai Lehtimäki4Jukka Peltola5Department of Neurology, Faculty of Medicine and Health Technology, Tampere UniversityDepartment of Neurosciences and Rehabilitation, Tampere University HospitalFaculty of Social Sciences, Health Sciences, Tampere UniversityImmunoregulation, Faculty of Medicine and Health Technology, Tampere UniversityDepartment of Neurosciences and Rehabilitation, Tampere University HospitalDepartment of Neurology, Faculty of Medicine and Health Technology, Tampere UniversityAbstract The aim of this study was to evaluate the effects of deep brain stimulation of the anterior nucleus of the thalamus (ANT-DBS) on systemic inflammatory responses in patients with drug-resistant epilepsy (DRE). Twenty-two Finnish patients with ANT-DBS implantation were enrolled in this pilot study. Changes in plasma interleukin-6 (IL-6) and interleukin-10 (IL-10) levels were examined using generalized estimating equation models at seven time points (before DBS surgery and 1, 2, 3, 6, 9 and 12 months after implantation). In the whole group, the IL-6/IL-10 ratio decreased significantly over time following ANT-DBS, while the decrease in IL-6 levels and increase in IL-10 levels were not significant. In the responder and nonresponder groups, IL-6 levels remained unchanged during the follow-up. Responders had significantly lower pre-DBS IL-10 levels before the ANT-DBS treatment than nonresponders, but the levels significantly increased over time after the treatment. In addition, responders had a higher pre-DBS IL-6/IL-10 ratio than nonresponders, and the ratio decreased for both groups after treatment, but the decrease did not reach the level of statistical significance. The rate of decrease in the ratio per month tended to be higher in responders than in nonresponders. These results may highlight the anti-inflammatory properties of ANT-DBS treatment associated with its therapeutic effectiveness in patients with DRE. Additional studies are essential to evaluate the potential of the proinflammatory cytokine IL-6, the anti-inflammatory cytokine IL-10, and their ratio as biomarkers to evaluate the therapeutic response to DBS treatment, which could facilitate treatment optimization.https://doi.org/10.1038/s41598-021-93265-x |
| spellingShingle | Pabitra Basnyat Soila Järvenpää Jani Raitanen Marko Pesu Kai Lehtimäki Jukka Peltola A 1-year follow-up study on immunological changes following deep brain stimulation in patients with epilepsy Scientific Reports |
| title | A 1-year follow-up study on immunological changes following deep brain stimulation in patients with epilepsy |
| title_full | A 1-year follow-up study on immunological changes following deep brain stimulation in patients with epilepsy |
| title_fullStr | A 1-year follow-up study on immunological changes following deep brain stimulation in patients with epilepsy |
| title_full_unstemmed | A 1-year follow-up study on immunological changes following deep brain stimulation in patients with epilepsy |
| title_short | A 1-year follow-up study on immunological changes following deep brain stimulation in patients with epilepsy |
| title_sort | 1 year follow up study on immunological changes following deep brain stimulation in patients with epilepsy |
| url | https://doi.org/10.1038/s41598-021-93265-x |
| work_keys_str_mv | AT pabitrabasnyat a1yearfollowupstudyonimmunologicalchangesfollowingdeepbrainstimulationinpatientswithepilepsy AT soilajarvenpaa a1yearfollowupstudyonimmunologicalchangesfollowingdeepbrainstimulationinpatientswithepilepsy AT janiraitanen a1yearfollowupstudyonimmunologicalchangesfollowingdeepbrainstimulationinpatientswithepilepsy AT markopesu a1yearfollowupstudyonimmunologicalchangesfollowingdeepbrainstimulationinpatientswithepilepsy AT kailehtimaki a1yearfollowupstudyonimmunologicalchangesfollowingdeepbrainstimulationinpatientswithepilepsy AT jukkapeltola a1yearfollowupstudyonimmunologicalchangesfollowingdeepbrainstimulationinpatientswithepilepsy AT pabitrabasnyat 1yearfollowupstudyonimmunologicalchangesfollowingdeepbrainstimulationinpatientswithepilepsy AT soilajarvenpaa 1yearfollowupstudyonimmunologicalchangesfollowingdeepbrainstimulationinpatientswithepilepsy AT janiraitanen 1yearfollowupstudyonimmunologicalchangesfollowingdeepbrainstimulationinpatientswithepilepsy AT markopesu 1yearfollowupstudyonimmunologicalchangesfollowingdeepbrainstimulationinpatientswithepilepsy AT kailehtimaki 1yearfollowupstudyonimmunologicalchangesfollowingdeepbrainstimulationinpatientswithepilepsy AT jukkapeltola 1yearfollowupstudyonimmunologicalchangesfollowingdeepbrainstimulationinpatientswithepilepsy |